Exhibitors Search
ProBio
Booth no.
B22
|
Exhibition
|
|NextRegenX |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
|2 Jeongja-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea |
|
Tel
|
|+82-2-6925-6609 |
|
Exhibits
|
| Antibody discovery and engineering, single B cell screening, cell line development, IND-enabling CMC, and process development and GMP manufacturing for plasmid DNA, mRNA, lentiviral vectors (LVV), and adeno-associated virus vectors (AAV). |
|
Company Type
|
| CRO / CMO Company |
Exhibitor Information
ProBio is a global CDMO providing end-to-end development and manufacturing services for biologics and cell and gene therapy(CGT). With GMP manufacturing facilities in New Jersey, USA, and China, ProBio helps biotech and pharmaceutical companies optimize drug development and accelerate time to market while providing support across the product lifecycle. Since October 2017, ProBio has supported customers across the United States, Europe, Asia-Pacific, and other regions in obtaining more than 160 IND approvals. This experience underpins its strong global development and regulatory capabilities.
Exhibit Description
ProBio uses hybridoma, single B cell screening, and phage display platforms to identify antibody candidates suited to specific targets and goals. Its biologics services span antibody engineering, cell line development, IND-enabling CMC, and GMP manufacturing. For cell and gene therapy (CGT), ProBio provides process development and characterization, analytical method development and validation, stability studies, and clinical and commercial GMP manufacturing for plasmid DNA, mRNA, LVV, and AAV.
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : Antibody discovery and engineering, single B-cell screening, cell line development, CMC services for IND submissions, and process development and GMPProBio provides antibody discovery, single B-cell screening, antibody engineering, cell line development, IND-enabling CMC development, and GMP manufacturing services for biologics. For cell and gene therapies (CGT), ProBio supports process and analytical method development, as well as clinical and commercial GMP manufacturing for plasmid DNA, mRNA, LVV, and AAV. Leveraging its global manufacturing sites in the United States and China, ProBio delivers one-stop solutions spanning early-stage development through commercial manufacturing.
KYUNGYON EXHIBITION CORP.
